The governance policies at Bio-Convert provides the company with a comprehensive structure ensuring practices to meet all legal and regulatory requirements. We further strive to implement good corporate governance to all stakeholders. Operations within Bio-Convert are conducted with utmost financial integrity, all decisions are taken in the best interests of the shareholders both for the minority and majority shareholders.

In 2024, Bio-Convert became a wholly owned subsidiary of the publicly traded U.S. life sciences business accelerator and holding company, Nordicus Partners Corporation (OTCQB: NORD).

Questions etc. can be assessed through our email info@bio-convert.com